CCFM1026+GL-104+MP108
N/A
Report date: 2024/01/17 15:00:49
Base Information
Drug NameCCFM1026+GL-104+MP108
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangnan University
China Registration ClassN/A
Develop Information
Other Information
ATC CodeN/A
Related LinksN/A